Transdermal delivery of ultradeformable cationic liposomes complexed with miR211-5p (UCL-211) stabilizes BRAFV600E+ melanocytic nevi
- PMID: 40032011
- PMCID: PMC12016659
- DOI: 10.1016/j.jconrel.2025.113586
Transdermal delivery of ultradeformable cationic liposomes complexed with miR211-5p (UCL-211) stabilizes BRAFV600E+ melanocytic nevi
Abstract
Small non-coding RNAs (e.g., siRNA, miRNA) are involved in a variety of melanocyte-associated skin conditions and act as drivers for alterations in gene expression within melanocytes. These molecular changes can potentially affect the cellular stability of melanocytes and promote their oncogenic transformation. Thus, small RNAs can be considered as therapeutic targets for these conditions, however, their transdermal delivery to the melanocytes through the epidermal barrier is challenging. We synthesized and extensively evaluated ultradeformable cationic liposome (UCLs) carriers complexed with synthetic microRNAs (miR211-5p; UCL-211) for transdermal delivery to melanocytes. UCL-211 complexes were characterized for their physicochemical properties, encapsulation efficiency, and deformability, which revealed a significant advantage over conventional liposomal carriers. Increased expression of miR211-5p stabilizes melanocytic nevi and keeps them in a growth-arrested state. We did a comprehensive assessment of cellular delivery, and biological activity of the miR211-5p carried by UCL-211 in vitro and their permeation through the epidermis of intact skin using ex vivo human skin tissue explants. We also demonstrated, in vivo, that transdermal delivery of miR211-5p by topical application of UCL-211 stabilized BRAFV600E+ nevi melanocytes in a benign nevi state.
Keywords: Melanocytes; Melanocytic nevi; Transdermal delivery; Ultradeformable cationic liposomes; miRNA delivery.
Copyright © 2025 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors have no competing interests to declare.
Update of
-
Transdermal Delivery of Ultradeformable Cationic Liposomes Complexed with miR211-5p (UCL-211) Stabilizes BRAFV600E+ Melanocytic Nevi.bioRxiv [Preprint]. 2024 Oct 21:2024.10.17.618694. doi: 10.1101/2024.10.17.618694. bioRxiv. 2024. Update in: J Control Release. 2025 May 10;381:113586. doi: 10.1016/j.jconrel.2025.113586. PMID: 39484595 Free PMC article. Updated. Preprint.
Similar articles
-
Transdermal Delivery of Ultradeformable Cationic Liposomes Complexed with miR211-5p (UCL-211) Stabilizes BRAFV600E+ Melanocytic Nevi.bioRxiv [Preprint]. 2024 Oct 21:2024.10.17.618694. doi: 10.1101/2024.10.17.618694. bioRxiv. 2024. Update in: J Control Release. 2025 May 10;381:113586. doi: 10.1016/j.jconrel.2025.113586. PMID: 39484595 Free PMC article. Updated. Preprint.
-
BRAFV600E induces reversible mitotic arrest in human melanocytes via microrna-mediated suppression of AURKB.Elife. 2021 Nov 23;10:e70385. doi: 10.7554/eLife.70385. Elife. 2021. PMID: 34812139 Free PMC article.
-
Ultradeformable cationic liposomes for delivery of small interfering RNA (siRNA) into human primary melanocytes.J Control Release. 2009 Feb 10;133(3):214-20. doi: 10.1016/j.jconrel.2008.10.003. Epub 2008 Oct 17. J Control Release. 2009. PMID: 18973779
-
Melanocytic nevi and melanoma: unraveling a complex relationship.Oncogene. 2017 Oct 19;36(42):5771-5792. doi: 10.1038/onc.2017.189. Epub 2017 Jun 12. Oncogene. 2017. PMID: 28604751 Free PMC article. Review.
-
Molecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma.Pigment Cell Melanoma Res. 2010 Feb;23(1):64-71. doi: 10.1111/j.1755-148X.2009.00645.x. Epub 2009 Sep 25. Pigment Cell Melanoma Res. 2010. PMID: 19788535 Review.
References
-
- Fitzpatrick TB and Breathnach A, The epidermal melanin unit system. Dermatologische Wochenschrift, 1963. 147: p. 481–489. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials